Recurrent laryngeal cancer after chemoradiation: salvage surgery versus re-irradiation
A 64-year-old woman with a T3N0 glottic SCC was treated 3 years ago with definitive concurrent chemoradiation (70 Gy, cisplatin). She now has a persistent, biopsy-proven local recurrence at the true vocal cord with supraglottic extension, 2.5 cm, without nodal or distant disease on PET-CT. She has significant radiation fibrosis, a tracheostomy for airway protection, and severe dysphagia requiring a feeding tube. She is medically fit for surgery (ASA 2, no major comorbidities). She asks whether she can have more radiation instead of a laryngectomy.
1. What is the standard of care for this recurrence, and what factors determine whether re-irradiation is a reasonable option?
Read the worked answer
For a resectable local recurrence after definitive chemoradiation, the standard of care is salvage total laryngectomy with neck dissection (bilateral if nodal risk warrants). Re-irradiation is generally reserved for unresectable recurrence, patients who decline surgery, or those who are not surgical candidates, and it carries high risks of carotid blowout, fistula, and dysphagia.
Factors favoring re-irradiation:
- Unresectable disease or patient refusal of laryngectomy.
- Adequate interval from prior RT (typically ≥6–12 months; here 3 years is favorable).
- Ability to spare critical structures (carotid, spinal cord) with modern techniques (IMRT, SBRT).
- Absence of severe radiation fibrosis and adequate performance status.
Here, the patient has severe fibrosis, a tracheostomy, and a feeding tube - features that make re-irradiation especially morbid. The recurrence is resectable, so laryngectomy is the recommended option. The discussion should be honest: re-irradiation in this setting has poor local control and high toxicity, and the patient should be counseled about the trade-offs.
2. How would you structure the counseling conversation about laryngectomy versus re-irradiation, including the impact on function and quality of life?
Read the worked answer
Use a structured, shared decision-making approach:
- Explain the options: salvage laryngectomy (standard) vs. re-irradiation (non-standard, higher risk, lower control).
- Discuss oncologic outcomes: laryngectomy offers the best chance of cure; re-irradiation has lower local control and higher complication rates.
- Discuss functional outcomes: laryngectomy means loss of natural voice (tracheoesophageal speech, electrolarynx, or esophageal speech), permanent stoma, and altered swallowing and airway care. Re-irradiation risks worsening dysphagia, fistula, and carotid blowout.
- Address the patient's values: her current tracheostomy and feeding tube already indicate significant functional impairment; laryngectomy may not worsen her current state as much as she fears, and it may improve airway security.
- Involve the multidisciplinary team: speech-language pathologist, radiation oncologist, and psychologist.
- Document the discussion and offer a second opinion if desired.
The conversation should be empathetic and allow time for questions; the patient should leave with a clear understanding that re-irradiation is not a like-for-like alternative to surgery.